Literature DB >> 4744024

Experience with cefazolin: an overall summary of pharmacologic and clinical trials in man.

J A Gold, J J McKee, D S Ziv.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4744024     DOI： 10.1093/infdis/128.supplement_2.s415

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  11 in total

1.  In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus.

Authors:  Mao Hagihara; Dora E Wiskirchen; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Activity of cefazolin against dense populations of enterobacteria.

Authors:  D Greenwood; C H Chan-Teoh; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  Disposition and dosage regimen of cephaloridine in calves.

Authors:  R K Chaudhary; A K Srivastava
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

Review 4.  Newer beta-lactam antibiotics.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1974       Impact factor: 3.553

5.  Cephamycins: a review, prospects and some original observations.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1975       Impact factor: 3.553

Review 6.  Treatment of respiratory tract infections with cephalosporin antibiotics.

Authors:  R Finch
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Comparative serum levels and protective activity of parenterally administered cephalosporins in experimental animals.

Authors:  L R Fare; P Actor; C Sachs; L Phillips; M Joloza; J F Pauls; J A Weisbach
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

Review 8.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

9.  Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.

Authors:  Esteban C Nannini; Martin E Stryjewski; Kavindra V Singh; Agathe Bourgogne; Tom H Rude; G Ralph Corey; Vance G Fowler; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2009-06-01       Impact factor: 5.191

10.  Treatment of osteomyelitis and septic arthritis with cefazolin.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.